Terumo Europe N.V.
Clinical trials sponsored by Terumo Europe N.V., explained in plain language.
Medical device manufacturer, subsidiary of Terumo Corporation.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Chemo-loaded microspheres aim to starve liver tumors from within Results expected Sep 2026 (estimated)